Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Engineered aminoacyl-tRNA synthetase/ribosomal machinery systems are synthetic biology tools comprising: (1) modified aminoacyl-tRNA synthetases, which specifically attach noncanonical amino acids to engineered tRNAs; (2) modified tRNAs that recognize unique or repurposed codons (such as stop codons or quadruplet codons); and (3) in some cases, engineered ribosomes altered to selectively translate these codons within the cell. Together, these allow incorporation of novel amino acids into proteins, enabling an expanded genetic code and the study or production of proteins with new properties. These systems are primarily used in research, biotechnology, and synthetic biology rather than direct therapeutic interventions.
For engineered aminoacyl-tRNA synthetase: Catalyzes attachment of noncanonical amino acids to engineered tRNAs, enabling their incorporation at designated codons during protein synthesis. For engineered ribosome: Facilitates translation of mRNAs containing unnatural codons, such as quadruplet codons or recoded amber (UAG) stop codons.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Engineered aminoacyl-tRNA synthetase and ribosomal translational machinery.